ANKRD13C

Across TCGA pan-cancer cohorts, ANKRD13C mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ANKRD13C data layer compared with 24 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher ANKRD13C mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated ANKRD13C expression acts as an unfavorable survival marker, although some lineages such as LSCC and LUAD show a favorable association.

LSCC and LUAD are the cancer types where ANKRD13C mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	OS	Median	All	0.979	0.645	.001	32	view →
LUAD	OS	Tertile	III,IV	0.931	0.343	.036	4	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

ANKRD13C–LSCC (OS)

Open the LSCC breakdown →